Paper32091066
Moderate cooling coprecipitation for extremely small iron oxide as a pH dependent T1-MRI contrast agent.
Chen B and 13 others. Nanoscale, 2020. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Moderate cooling coprecipitation for extremely small iron oxide as a pH dependent T1-MRI contrast agent. Papers, record 32091066. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32091066
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Moderate cooling coprecipitation for extremely small iron oxide as a pH dependent T1-MRI contrast agent.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contrast Media | Major topic |
| Ferric Compounds | Major topic |
| Magnetic Resonance Imaging | Major topic |
| Animals | |
| Brain | |
| Cell Survival | |
| Ferrosoferric Oxide | |
| Hydrogen-Ion Concentration | |
| Mesenchymal Stem Cells | |
| Nanoparticles | |
| Particle Size | |
| Rats | |
| Temperature |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41343885 | Superparamagnetic iron oxide nanoparticles in clinical applications: current status and future perspectives. | EBioMedicine | 2025 | https://conductscience.org/library/papers/41343885 | PubMed |
| 40284493 | Applications and Efficacy of Iron Oxide Nanoparticles in the Treatment of Brain Tumors. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284493 | PubMed |
| 39791792 | Iron Oxide Nanoparticle-Based T1 Contrast Agents for Magnetic Resonance Imaging: A Review. | Nanomaterials (Basel) | 2024 | https://conductscience.org/library/papers/39791792 | PubMed |
| 38633040 | Ultrasmall Mn-doped iron oxide nanoparticles with dual hepatobiliary and renal clearances for T1 MR liver imaging. | Nanoscale Adv | 2024 | https://conductscience.org/library/papers/38633040 | PubMed |
| 36902163 | Cellular 1H MR Relaxation Times in Healthy and Cancer Three-Dimensional (3D) Breast Cell Culture. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36902163 | PubMed |
| 34239302 | Neurite Extension and Orientation of Spiral Ganglion Neurons Can Be Directed by Superparamagnetic Iron Oxide Nanoparticles in a Magnetic Field. | Int J Nanomedicine | 2021 | https://conductscience.org/library/papers/34239302 | PubMed |
| 34093865 | Improving the sensitivity of T1 contrast-enhanced MRI and sensitive diagnosing tumors with ultralow doses of MnO octahedrons. | Theranostics | 2021 | https://conductscience.org/library/papers/34093865 | PubMed |
| 32517085 | Magnetic Nanomaterials as Contrast Agents for MRI. | Materials (Basel) | 2020 | https://conductscience.org/library/papers/32517085 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32091066
GET https://conductscience.org/api/papers/v1/32091066/authors